International Extranodal Lymphoma Study Group (ielsg)
Clinical trials sponsored by International Extranodal Lymphoma Study Group (ielsg), explained in plain language.
-
New hope for brain lymphoma: study tests best treatment path
Disease control CompletedThis study looked at 227 adults with newly diagnosed primary CNS lymphoma, a rare brain cancer. It compared different chemotherapy combinations (with or without rituximab and thiotepa) followed by either whole-brain radiation or a stem cell transplant. The goal was to see which a…
Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control
Last updated May 17, 2026 08:16 UTC
-
Antibiotic may control rare eye cancer without chemo
Disease control CompletedThis study tested whether the antibiotic doxycycline can control a rare lymphoma of the eye that is linked to a bacterial infection. 44 newly diagnosed patients received prolonged doxycycline, and if the infection returned, they were retreated. The goal was to see how long the ca…
Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control
Last updated May 15, 2026 12:07 UTC